Artificial Intelligence in Drug Discovery

Reference

1. Vamathevan, J., Clark, D., Czodrowski, P., et al. (2019). Applications of machine learning in drug discovery and development. Nature Reviews Drug Discovery, 18(6), 463–477. https://doi.org/10.1038/s41573-019-0024-5   
2. Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018). The rise of deep learning in drug discovery. Drug Discovery Today, 23(6), 1241–1250.  https://doi.org/10.1016/j.drudis.2018.01.039   
3. Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., et al. (2019). Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nature Biotechnology, 37(9), 1038–1040. https://doi.org/10.1038/s41587-019-0224-x   
4. Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016). DeepTox: Toxicity prediction using deep learning. Frontiers in Environmental Science, 3, 80.           https://doi.org/10.3389/fenvs.2015.00080   
5. Amann, J., Blasimme, A., Vayena, E., Frey, D., & Madai, V. I. (2020). Explainability for artificial intelligence in healthcare: A multidisciplinary perspective. BMC Medical Informatics and Decision Making, 20(1), 310. https://doi.org/10.1186/s12911-020-01332-6   
6. Walters, W. P., & Murcko, M. A. (2020). Assessing the impact of generative AI on medicinal chemistry. Nature Biotechnology, 38, 143–145.  https://doi.org/10.1038/s41587-019-0361-2   
7. Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018). The rise of deep learning in drug discovery. Drug Discovery Today, 23(6), 1241–1250. https://doi.org/10.1016/j.drudis.2018.01.039   
8. Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., ... & Collins, J. J. (2020). A deep learning approach to antibiotic discovery. Cell, 180(4), 688–702.e13. https://doi.org/10.1016/j.cell.2020.01.021   
9. Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., ... & Aspuru-Guzik, A. (2019). Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nature Biotechnology, 37(9), 1038–1040. https://doi.org/10.1038/s41587-019-0224-x   
10. Mak, K.-K., & Pichika, M. R. (2019). Artificial intelligence in drug development: Present status and future prospects. Drug Discovery Today, 24(3), 773–780. https://doi.org/10.1016/j.drudis.2018.11.014   
11. Zhou, J., Wang, Q., Pan, S., & Du, X. (2020). Artificial intelligence in COVID-19 drug repurposing. The Lancet Digital Health, 2(12), e667–e676. https://doi.org/10.1016/S25897500(20)30223-4   
12. Pereira, J. C., Caffarena, E. R., & dos Santos, C. N. (2016). Boosting dockingbased virtual screening with deep learning. Journal of Chemical Information and Modeling, 56(12), 2495– 2506. https://doi.org/10.1021/acs.jcim.6b00340   
13. Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018). The rise of deep learning in drug discovery. Drug Discovery Today, 23(6), 1241–1250. https://doi.org/10.1016/j.drudis.2018.01.039   
14. Ching, T., Himmelstein, D. S., Beaulieu-Jones, B. K., Kalinin, A. A., Do, B. T., Way, G. P., ... & Greene, C. S. (2018). Opportunities and obstacles for deep learning in biology and medicine. Journal of the Royal Society Interface, 15(141), 20170387. https://doi.org/10.1098/rsif.2017.0387   
15. Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., ... & Hassabis, D. (2021). Highly accurate protein structure prediction with AlphaFold. Nature, 596(7873), 583–589. https://doi.org/10.1038/s41586-021-03819-2   
16. Senior, A. W., Evans, R., Jumper, J., Kirkpatrick, J., Sifre, L., Green, T., ... & Kavukcuoglu, K. (2020). Improved protein structure prediction using potentials from deep learning. Nature, 577(7792), 706–710. https://doi.org/10.1038/s41586019-1923-7   
17. Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., ... & Zhao, S. (2019). Applications of machine learning in drug discovery and development. Nature Reviews Drug Discovery, 18(6), 463–477.   https://doi.org/10.1038/s41573-019-0024-5   
18. Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., ... & Aspuru-Guzik, A. (2019). Deep learning enables rapid   
19. Callaway, E. (2020). ‘It will change everything’: DeepMind’s AI makes gigantic leap in solving protein structures. Nature, 588(7837), 203–204. https://doi.org/10.1038/d41586020-03348-4  
20. Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., ... & Hassabis, D. (2021). Highly accurate protein structure prediction with AlphaFold. Nature, 596(7873), 583–589. https://doi.org/10.1038/s41586-021-03819-2  
21. Senior, A. W., Evans, R., Jumper, J., Kirkpatrick, J., Sifre, L., Green, T., ... & Kavukcuoglu, K. (2020). Improved protein structure prediction using potentials from deep learning. Nature, 577(7792), 706–710. https://doi.org/10.1038/s41586019-1923-7  
22. Tunyasuvunakool, K., Adler, J., Wu, Z., Green, T., Zielinski, M., ?ídek, A., ... & Hassabis, D. (2021). Highly accurate protein structure prediction for the human proteome. Nature, 596(7873), 590–596. https://doi.org/10.1038/s41586-021-03828-1  
23. Anighoro, A., Bajorath, J., & Rastelli, G. (2014). Polypharmacology: Challenges and opportunities in drug discovery. Journal of Medicinal Chemistry, 57(19), 7874–7887. https://doi.org/10.1021/jm5006463 
24. Bocci, G., Cassetta, L., & Gozzi, G. (2017). In silico prediction of off-targets for improved drug safety. Frontiers in Pharmacology, 8, 280. https://doi.org/10.3389/fphar.2017.00280 
25. Hopkins, A. L. (2008). Network pharmacology: The next paradigm in drug discovery. Nature Chemical Biology, 4(11), 682–690. https://doi.org/10.1038/nchembio.118 
26. Pushpakom, S., Iorio, F., Eyers, P. A., et al. (2019). Drug repurposing: Progress, challenges and recommendations. Nature Reviews Drug Discovery, 18(1), 41–58. https://doi.org/10.1038/nrd.2018.168 
27. Ryu, J. Y., Kim, H. U., & Lee, S. Y. (2018). Deep learning improves prediction of drug– drug and drug–target interactions. Proceedings of the National Academy of Sciences, 115(18), E4304–E4311. https://doi.org/10.1073/pnas.1803294115 
28. Sterling, T., & Irwin, J. J. (2015). ZINC 15 – Ligand discovery for everyone. Journal of Chemical Information and Modeling, 55(11), 2324–2337. https://doi.org/10.1021/acs.jcim.5b00559 
29. Wishart, D. S., Feunang, Y. D., Guo, A. C., et al. (2018). DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Research, 46(D1), D1074–D1082. https://doi.org/10.1093/nar/gkx1037 
30. Xiong, G., Luo, Y., Ji, W., et al. (2024). Artificial intelligence for polypharmacology and multi-target drug discovery. International Journal of Molecular Sciences, 25(14), 6996. https://doi.org/10.3390/ijms25146996 
31. Coley, C. W., Eyke, N. S., & Jensen, K. F. (2019). Autonomous discovery in the chemical sciences part II: Outlook. Accounts of Chemical Research, 53(5), 895–906. https://doi.org/10.1021/acs.accounts.9b00640 
32. Schwaller, P., Laino, T., Gaudin, T., Bolgar, P., Hunter, C. A., Bekas, C., & Lee, A. A. (2020). Machine intelligence for chemical reaction prediction. Chemical Science, 11(2), 331– 339. https://doi.org/10.1039/C9SC05704H 
33. Segler, M. H. S., Preuss, M., & Waller, M. P. (2018). Planning chemical syntheses with deep neural networks and symbolic AI. Nature, 555(7698), 604–610. https://doi.org/10.1038/nature25978 
34. DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016). Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47, 20,33. https://doi.org/10.1016/j.jhealeco.2016.01.012 
35. Harrer, S., Shah, P., Antony, B., & Hu, J. (2019). Artificial intelligence for clinical trial design. Trends in Pharmacological Sciences, 40(8), 577–591. https://doi.org/10.1016/j.tips.2019.06.004 
36. Jumper, J., Evans, R., Pritzel, A., et al. (2021). Highly accurate protein structure prediction with AlphaFold. Nature, 596(7873), 583–589. https://doi.org/10.1038/s41586-021-03819-2 
37. Wallach, I., Dzamba, M., & Heifets, A. (2015). AtomNet: A deep convolutional neural network for bioactivity prediction in structure-based drug discovery. arXiv preprint arXiv:1510.02855. 
38. Wong, C. H., Siah, K. W., & Lo, A. W. (2019). Estimation of clinical trial success rates and related parameters. Biostatistics, 20(2), 273–286. https://doi.org/10.1093/biostatistics/kxx069 
39. Yu, K. H., Beam, A. L., & Kohane, I. S. (2018). Artificial intelligence in healthcare. Nature Biomedical Engineering, 2(10), 719–731. https://doi.org/10.1038/s41551-018-0305-z 
40. Baek, M., DiMaio, F., Anishchenko, I., et al. (2021). Accurate prediction of protein structures and interactions using a three-track neural network. Science, 373(6557), 871–876. https://doi.org/10.1126/science.abj8754
41. Chawla, N. V., Bowyer, K. W., Hall, L. O., & Kegelmeyer, W. P. (2002). SMOTE: Synthetic minority oversampling technique. Journal of Artificial Intelligence Research, 16, 321–357.  https://doi.org/10.1613/jair.953
42. Hey, T., Tansley, S., & Tolle, K. (2009). The Fourth Paradigm: Data-Intensive Scientific Discovery. Microsoft Research.
43. Mak, K. K., & Pichika, M. R. (2019). Artificial intelligence in drug development: Present status and future prospects. Drug Discovery Today, 24(3), 773–780. https://doi.org/10.1016/j.drudis.2018.11.014
44. Szklarczyk, D., Gable, A. L., Lyon, D., et al. (2021). STRING v11: Protein–protein association networks with increased coverage, supporting functional discovery in genome-wide datasets. Nucleic Acids Research, 47(D1), D607–D613. https://doi.org/10.1093/nar/gky1131
45. Topol, E. J. (2019). High-performance medicine: The convergence of human and artificial intelligence. Nature Medicine, 25(1), 44–56. https://doi.org/10.1038/s41591-018-0300-7
46. Vamathevan, J., Clark, D., Czodrowski, P., et al. (2019). Applications of machine learning in drug discovery and development. Nature Reviews Drug Discovery, 18(6), 463–477. https://doi.org/10.1038/s41573-019-0024-5
47. Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., et al. (2019). Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nature Biotechnology, 37(9), 1038–1040. https://doi.org/10.1038/s41587019-0224-x.